SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-18-009608
Filing Date
2018-07-25
Accepted
2018-07-25 09:22:45
Documents
1
Period of Report
2018-07-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 4183
  Complete submission text file 0001213900-18-009608.txt   5823
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128
Business Address
Pearson Mark E. (Reporting) CIK: 0001486558 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14778 | Film No.: 18967818